Company: CYTK
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013167
Chunk: 101

Company: CYTOKINETICS INC
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 101
---
. By Order of the Board of Directors /s/ John O. Faurescu John O. Faurescu, Esq. Associate General Counsel & Corporate Secretary Dated: April 10, 2025

| Cytokinetics, Inc.|2025 Proxy Statement |     | 71 |

TABLE OF CONTENTS APPENDIX A CYTOKINETICS, INCORPORATED AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN AMENDED BY THE BOARD OF DIRECTORS: FEBRUARY 6, 2013 APPROVED BY STOCKHOLDERS: MAY 22, 2013 AMENDED TO REFLECT THE REVERSE STOCK SPLIT: JUNE 25, 2013 AMENDED AND RESTATED BY THE BOARD OF DIRECTORS: FEBRUARY 3, 2015 APPROVED BY STOCKHOLDERS: MAY 20, 2015 AMENDED AND RESTATED BY THE BOARD OF DIRECTORS: FEBRUARY 10, 2017 APPROVED BY STOCKHOLDERS: MAY 18, 2017 AMENDED AND RESTATED BY THE BOARD OF DIRECTORS: FEBRUARY 7, 2019 APPROVED BY STOCKHOLDERS: MAY 15, 2019 AMENDED TO REFLECT SEPARATE INDUCEMENT POOL: MAY 14, 2020 AMENDED AND RESTATED BY THE BOARD OF DIRECTORS: FEBRUARY 18, 2021 APPROVED BY THE STOCKHOLDERS: MAY 12, 2021 AMENDED AND RESTATED TO INCREASE SEPARATE INDUCEMENT POOL: AUGUST 13, 2021 AMENDED AND RESTATED BY THE BOARD OF DIRECTORS: FEBRUARY 17, 2022 APPROVED BY THE STOCKHOLDERS: MAY 10, 2022 AMENDED AND RESTATED TO INCREASE SEPARATE INDUCEMENT POOL: MAY 26, 2022 AMENDED AND RESTATED TO INCREASE SEPARATE INDUCMENT POOL: MARCH 1, 2023 AMENDED AND RESTATED BY THE BOARD OF DIRECTORS: FEBRUARY 17, 2025 APPROVED BY THE STOCKHOLDERS: MAY 14, 2025 1. PURPOSES OF THE PLAN AND PERMITTED AWARDS. The purposes of this Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to Employees, Directors and